189 related articles for article (PubMed ID: 26379435)
1. Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin-pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro.
Uram Ł; Szuster M; Filipowicz A; Gargasz K; Wołowiec S; Wałajtys-Rode E
Int J Nanomedicine; 2015; 10():5647-61. PubMed ID: 26379435
[TBL] [Abstract][Full Text] [Related]
2. In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate.
Uram Ł; Szuster M; Gargasz K; Filipowicz A; Wałajtys-Rode E; Wołowiec S
Int J Nanomedicine; 2013; 8():4707-20. PubMed ID: 24376351
[TBL] [Abstract][Full Text] [Related]
3. The effect of G3 PAMAM dendrimer conjugated with B-group vitamins on cell morphology, motility and ATP level in normal and cancer cells.
Uram Ł; Szuster M; Misiorek M; Filipowicz A; Wołowiec S; Wałajtys-Rode E
Eur J Pharm Sci; 2017 May; 102():275-283. PubMed ID: 28323116
[TBL] [Abstract][Full Text] [Related]
4. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the localization and biological effects of PAMAM G3 dendrimer-biotin/pyridoxal conjugate as HaCaT keratinocyte targeted nanocarrier.
Szuster M; Uram ŁS; Filipowicz-Rachwał A; Wołowiec S; Wałajtys-Rode E
Acta Biochim Pol; 2019 Apr; 66(2):191-200. PubMed ID: 30964128
[TBL] [Abstract][Full Text] [Related]
6. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
Uram Ł; Filipowicz A; Misiorek M; Pieńkowska N; Markowicz J; Wałajtys-Rode E; Wołowiec S
Eur J Pharm Sci; 2018 Nov; 124():1-9. PubMed ID: 30118847
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells.
Uram Ł; Filipowicz-Rachwał A; Misiorek M; Winiarz A; Wałajtys-Rode E; Wołowiec S
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480608
[TBL] [Abstract][Full Text] [Related]
8. Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and
Markowicz J; Uram Ł; Wołowiec S; Rode W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884739
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs.
Lu J; Li N; Gao Y; Li N; Guo Y; Liu H; Chen X; Zhu C; Dong Z; Yamamoto A
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103462
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
Uram Ł; Misiorek M; Pichla M; Filipowicz-Rachwał A; Markowicz J; Wołowiec S; Wałajtys-Rode E
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652556
[TBL] [Abstract][Full Text] [Related]
11. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity.
Shao N; Su Y; Hu J; Zhang J; Zhang H; Cheng Y
Int J Nanomedicine; 2011; 6():3361-72. PubMed ID: 22267921
[TBL] [Abstract][Full Text] [Related]
12. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
13. Mixed-Generation PAMAM G3-G0 Megamer as a Drug Delivery System for Nimesulide: Antitumor Activity of the Conjugate Against Human Squamous Carcinoma and Glioblastoma Cells.
Zaręba M; Sareło P; Kopaczyńska M; Białońska A; Uram Ł; Walczak M; Aebisher D; Wołowiec S
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31601050
[TBL] [Abstract][Full Text] [Related]
14. Biotin-Containing Third Generation Glucoheptoamidated Polyamidoamine Dendrimer for 5-Aminolevulinic Acid Delivery System.
Kaczorowska A; Malinga-Drozd M; Kałas W; Kopaczyńska M; Wołowiec S; Borowska K
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671436
[TBL] [Abstract][Full Text] [Related]
15. Fabrication, characterization and in vitro evaluation of poly(D,L-lactide-co-glycolide) microparticles loaded with polyamidoamine-plasmid DNA dendriplexes for applications in nonviral gene delivery.
Intra J; Salem AK
J Pharm Sci; 2010 Jan; 99(1):368-84. PubMed ID: 19670295
[TBL] [Abstract][Full Text] [Related]
16. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
[TBL] [Abstract][Full Text] [Related]
18. Modified PAMAM dendrimer with 4-carbomethoxypyrrolidone surface groups-its uptake, efflux, and location in a cell.
Janaszewska A; Studzian M; Petersen JF; Ficker M; Paolucci V; Christensen JB; Tomalia DA; Klajnert-Maculewicz B
Colloids Surf B Biointerfaces; 2017 Nov; 159():211-216. PubMed ID: 28797971
[TBL] [Abstract][Full Text] [Related]
19. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
Goldberg DS; Vijayalakshmi N; Swaan PW; Ghandehari H
J Control Release; 2011 Mar; 150(3):318-25. PubMed ID: 21115079
[TBL] [Abstract][Full Text] [Related]
20. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
